309 related articles for article (PubMed ID: 19695863)
1. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey.
Lévy-Bruhl D; Bousquet V; King LA; O'Flanagan D; Bacci S; Lopalco PL; Salmaso S;
Eur J Cancer; 2009 Oct; 45(15):2709-13. PubMed ID: 19695863
[TBL] [Abstract][Full Text] [Related]
2. Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey.
King LA; Lévy-Bruhl D; O'Flanagan D; Bacci S; Lopalco PL; Kudjawu Y; Salmaso S;
Euro Surveill; 2008 Aug; 13(33):. PubMed ID: 18761891
[TBL] [Abstract][Full Text] [Related]
3. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.
Dorleans F; Giambi C; Dematte L; Cotter S; Stefanoff P; Mereckiene J; O'Flanagan D; Lopalco PL; D'Ancona F; Levy-Bruhl D;
Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144444
[TBL] [Abstract][Full Text] [Related]
4. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
5. [Vaccines against human papillomavirus (HPV); between registration and implementation].
van Rossum TG; de Melker HE; Houweling H; Voordouw AC; Meijer CJ; Helmerhorst TJ; Kretzschmar M; Berkhof J; van der Noordaa J
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):987-92. PubMed ID: 18549172
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
8. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against human papillomavirus.
BMJ Group
Drug Ther Bull; 2008 Dec; 46(12):89-93. PubMed ID: 19056700
[TBL] [Abstract][Full Text] [Related]
10. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
[No Abstract] [Full Text] [Related]
11. [Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands].
de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2001-4. PubMed ID: 18825885
[TBL] [Abstract][Full Text] [Related]
12. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
13. Preparing for HPV vaccination in South Africa: key challenges and opinions.
Harries J; Moodley J; Barone MA; Mall S; Sinanovic E
Vaccine; 2009 Jan; 27(1):38-44. PubMed ID: 18977271
[TBL] [Abstract][Full Text] [Related]
14. [How does it go on with the HPV vaccination?].
Kaulen H
Dtsch Med Wochenschr; 2007 Jan; 132(4):132. PubMed ID: 17338090
[No Abstract] [Full Text] [Related]
15. WHO position on HPV vaccines.
World Health Organization
Vaccine; 2009 Dec; 27(52):7236-7. PubMed ID: 19450645
[TBL] [Abstract][Full Text] [Related]
16. [Resolution of the HPV Vaccine Working Group of December 12, 2006].
Vonka V; Hamsíková E;
Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):94-8. PubMed ID: 17593807
[No Abstract] [Full Text] [Related]
17. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
[TBL] [Abstract][Full Text] [Related]
18. Three provinces to study 2-dose HPV vaccine.
Eggertson L
CMAJ; 2007 Aug; 177(5):444-5. PubMed ID: 17724315
[No Abstract] [Full Text] [Related]
19. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
Knudtson M; Tiso S; Phillips S
Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
[TBL] [Abstract][Full Text] [Related]
20. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
Gendel JE
Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
